The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Weighted Avg Shares
Average number of basic shares outstanding during the period, used to calculate basic EPS.
The Joint Corp.NASDAQ: JYNT
Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026
Weighted avg shares declines year over year
Q1 FY2026 weighted avg shares of 14.18M shares fell 6.6% year over year, behind the -1.0% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 2.6% from the prior quarter. Over 3 fiscal years it compounded at +1.5% a year.
Context
- Weighted avg shares increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -6.6% toward the trailing-twelve-month pace of -1.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares history
Shares · from the income statement
- Latest · FY2025
- 15.13M USD
- Year-over-year change
- +1.4%
- 4-year CAGR
- +1.4%
| Period | Period end | Weighted Avg Shares | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 15.13M | +1.4% |
| FY2024 | 2024-12-31 | 14.92M | +1.6% |
| FY2023 | 2023-12-31 | 14.69M | +1.4% |
| FY2022 | 2022-12-31 | 14.49M | +1.2% |
| FY2021 | 2021-12-31 | 14.32M | — |
Weighted Avg Shares vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 weighted avg shares of 14.85M shares is the lowest of the 11 companies compared; the peer median is 64.82M shares.
- Its year-over-year change of -1.0% is the 9th highest of 11, against a peer median of +54.5%.
- Over three fiscal years its annual growth of +1.5% compares with a peer median of +38.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | 123.97M | +665.1% | +192.4% | |
| LTM Mar 2026 | 102.76M | +82.6% | +41.3% | |
| LTM Mar 2026 | 98.96M | -2.8% | -0.7% | |
| LTM Mar 2026 | 94.17M | +114.9% | +186.0% | |
| LTM Mar 2026 | 79.93M | +69.4% | +35.9% | |
| LTM Mar 2026 | 49.71M | +39.7% | +15.5% | |
| LTM Mar 2026 | 44.81M | +2.4% | +1.7% | |
| LTM Mar 2026 | 41.45M | +15.9% | +6.9% | |
| LTM Mar 2026 | 31.06M | -2.1% | +57.2% | |
| LTM Mar 2026 | 30.8M | +191004.4% | +2642.4% | |
| LTM Mar 2026 | 14.85M | -1.0% | +1.5% | |
| Peer median (excluding JYNT) | 64.82M | +54.5% | +38.6% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 80.01M | 101.25M | 46.98M | 52.16M | 54.9M |
| Cost of Revenue | 7.67M | 9.17M | 10.48M | 11.52M | 11.23M |
| Gross Profit | 72.35M | 92.08M | 36.5M | 40.65M | 43.67M |
| Gross Margin | 90.4% | 90.9% | 77.7% | 77.9% | 79.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 62.27M | 81.95M | 34.92M | 41.1M | 42.93M |
| Operating Expenses | 66.22M | 91.25M | 36.18M | 42.54M | 44.58M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| EBITDA | 10.07M | 7.89M | 8.88M | 2.9M | 1.48M |
| EBITDA Margin | 12.6% | 7.8% | 18.9% | 5.6% | 2.7% |
| Operating Income | 6.13M | 828.25K | 318.3K | (1.89M) | (905.48K) |
| Operating Margin | 7.7% | 0.8% | 0.7% | -3.6% | -1.6% |
| Interest Income | 0 | 133.1K | 0 | 280.29K | 0 |
| Interest Expense | 0 | 953.53K | 64.29K | 0 | 0 |
| Other Income / Expenses | (69.88K) | (133.1K) | (64.29K) | 280.29K | 675.97K |
| Income Before Tax | 6.06M | 695.15K | 254.01K | (1.61M) | (229.5K) |
| Pre-Tax Margin | 7.6% | 0.7% | 0.5% | -3.1% | -0.4% |
| Income Tax Expense | (1.51M) | 68.45K | 11.02M | 5.61K | 38.65K |
| Net Income | 7.57M | 626.71K | (9.75M) | (5.8M) | 2.91M |
| Net Margin | 9.5% | 0.6% | -20.8% | -11.1% | 5.3% |
| EPS (Basic) | 0.46 | 0.04 | (0.66) | (0.39) | 0.19 |
| EPS (Diluted) | 0.44 | 0.04 | (0.66) | (0.39) | 0.19 |
| Weighted Avg Shares | 14.32M | 14.49M | 14.69M | 14.92M | 15.13M |
| Weighted Avg Shares (Diluted) | 14.94M | 14.87M | 14.69M | 15.15M | 15.13M |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.